In a report released today, Andrew Mok CFA from Barclays maintained a Hold rating on Privia Health Group (PRVA – Research Report), with a price target of $22.00. The company’s shares closed last Friday at $18.54.
Mok CFA covers the Healthcare sector, focusing on stocks such as DaVita, HCA Healthcare, and Encompass Health. According to TipRanks, Mok CFA has an average return of -5.4% and a 47.19% success rate on recommended stocks.
Privia Health Group has an analyst consensus of Strong Buy, with a price target consensus of $28.08.
The company has a one-year high of $30.15 and a one-year low of $17.54. Currently, Privia Health Group has an average volume of 979.5K.
Based on the recent corporate insider activity of 76 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of PRVA in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Privia Health Group (PRVA) Company Description:
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
Read More on PRVA:
- Privia Health to Report First Quarter 2024 Results on Thursday, May 9
- Privia Health price target lowered to $37 from $41 at Canaccord
- Barclays starts health care facilities, managed care group with Neutral view
- Privia Health initiated with an Equal Weight at Barclays
- Privia Health price target lowered to $26 from $30 at TD Cowen
